Jorge C. Escalante-Semerena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jorge C. Escalante-Semerena has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Chelsey M. VanDrisse
Department of Genetics, University of Georgia
6 shared publications - Rachel M. Burckhardt
American Academy of Microbiology, Washington, DC, USA
6 shared publications - Flavia Gisela Costa
Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus
5 shared publications - Ivan Rayment
The Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706
5 shared publications - Anastacia R. Parks
Department of Microbiology, University of Georgia, Athens, GA 30602, USA
4 shared publications Kristy L. Hentchel
Department of Microbiology, University of Georgia, Athens, Georgia, USA
4 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (9)
Cobamide excretion allows Salmonella to transition from its anaerobic to aerobic lifestyle
Cobamides (Cbas) are structurally complex biomolecules used by cells of all domains of life. However, de novo Cba biosynthesis occurs only in some bacteria and archaea. The uptake, salvage, and remodeling of Cbas and their precursors have been well studied in several prokaryotes, but our understanding of the mechanism(s) of Cba release into the environment is limited. In this study, we quantitatively demonstrate Cba excretion by Salmonella enterica subsp. enterica sv. Typhimurium strain LT2 (hereafter S . Typhimurium). We performed experiments in liquid and solid media using strains that produced Cbas from a precursor that can be converted to Cbas in the presence of oxygen. We show that under anaerobic conditions, S . Typhimurium synthesizes Cbas de novo and excretes this valuable cofactor into the medium. To do this, S . Typhimurium requires ≥24 h of incubation under anaerobic conditions to form microcolonies that can continue synthesizing and excreting Cbas when shifted to aerobic growth conditions. We propose that de novo Cba biosynthesis and excretion may be necessary for S . Typhimurium to transition from an anaerobic to an aerobic environment, and that Cba excretion may allow growth of Cba-requiring members of polymicrobial communities. IMPORTANCE: This work is important for several reasons. First, this is the first evidence that Salmonella enterica subsp. enterica sv. Typhimurium strain LT2 excretes cobamides, a valuable nutrient for all forms of life, including humans. Second, although de novo cobamide biosynthesis in S . Typhimurium is blocked by oxygen, we show that once a microcolony of S . Typhimurium is formed under anaerobic conditions, exposure to air does not block cobamide biosynthesis, and robust colony growth can proceed. Hence, the formation of microcolonies under anaerobic conditions may be a critical strategy for S . Typhimurium survival in its free-living lifestyle. Third, in an environment where S . Typhimurium is part of a polymicrobial community, this pathogen may allow growth of other microbes that require cobamides to survive, as it may occur in polymicrobial biofilms. Finally, this work provides the groundwork for advancing our understanding of why S . Typhimurium excretes such a valuable cofactor and how excretion is accomplished.
- 1 September 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (9)
Open AccessCobamide excretion allows Salmonella to transition from its anaerobic to aerobic lifestyle
Cobamides (Cbas) are structurally complex biomolecules used by cells of all domains of life. However, de novo Cba biosynthesis occurs only in some bacteria and archaea. The uptake, salvage, and remodeling of Cbas and their precursors have been well studied in several prokaryotes, but our understanding of the mechanism(s) of Cba release into the environment is limited. In this study, we quantitatively demonstrate Cba excretion by Salmonella enterica subsp. enterica sv. Typhimurium strain LT2 (hereafter S . Typhimurium). We performed experiments in liquid and solid media using strains that produced Cbas from a precursor that can be converted to Cbas in the presence of oxygen. We show that under anaerobic conditions, S . Typhimurium synthesizes Cbas de novo and excretes this valuable cofactor into the medium. To do this, S . Typhimurium requires ≥24 h of incubation under anaerobic conditions to form microcolonies that can continue synthesizing and excreting Cbas when shifted to aerobic growth conditions. We propose that de novo Cba biosynthesis and excretion may be necessary for S . Typhimurium to transition from an anaerobic to an aerobic environment, and that Cba excretion may allow growth of Cba-requiring members of polymicrobial communities. IMPORTANCE: This work is important for several reasons. First, this is the first evidence that Salmonella enterica subsp. enterica sv. Typhimurium strain LT2 excretes cobamides, a valuable nutrient for all forms of life, including humans. Second, although de novo cobamide biosynthesis in S . Typhimurium is blocked by oxygen, we show that once a microcolony of S . Typhimurium is formed under anaerobic conditions, exposure to air does not block cobamide biosynthesis, and robust colony growth can proceed. Hence, the formation of microcolonies under anaerobic conditions may be a critical strategy for S . Typhimurium survival in its free-living lifestyle. Third, in an environment where S . Typhimurium is part of a polymicrobial community, this pathogen may allow growth of other microbes that require cobamides to survive, as it may occur in polymicrobial biofilms. Finally, this work provides the groundwork for advancing our understanding of why S . Typhimurium excretes such a valuable cofactor and how excretion is accomplished.
- Open Access
- 5 June 2026
- Published by Wiley in Molecular Microbiology
- Vol. 126 (2) , 129-144
Protein STM3547 From Salmonella typhimurium Is a Phosphofructose Kinase B‐Type Enzyme With Ribose Kinase Activity
The first step in the metabolic utilization of ribose is the phosphorylation of its 5′ hydroxyl group. The enteropathogenic bacterium Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) has two known enzymes that can phosphorylate D‐ribose, namely ribose kinase (RbsK) and deoxyribose kinase (DeoK). Here, we report in vivo and in vitro evidence to support the conclusion that the previously uncharacterized STM3547 protein of this bacterium has ribose kinase activity, and we propose naming it RikA (Ribokinase A). Our bioinformatics analyses show end‐to‐end sequence identity/similarity among RikA, RbsK, and DeoK, and site‐directed mutagenesis of RikA showed that, like in RbsK and DeoK, an aspartate residue (position 343 in RikA) is critical for enzymatic activity. We found that RikA has K m values comparable to those of RbsK and DeoK for both ribose and ATP, and that all three proteins display cooperative binding of ATP induced by ribose. Together, these data suggest that the ribose‐induced conformational changes observed in E. coli RbsK also occur in all three ribose kinases of S. typhimurium . Notably, while RikA has robust ribose kinase activity, it can only poorly phosphorylate 2‐deoxy‐D‐ribose, D‐xylose, and D‐xylulose, and it cannot phosphorylate L‐arabinose. Collectively, our data support the conclusion that the RikA protein is a member of the phosphofructose kinase B‐type (PfkB) family of sugar kinases.
- 5 June 2026
- Published by Wiley in Molecular Microbiology
- Vol. 126 (2) , 129-144
Open AccessProtein STM3547 From Salmonella typhimurium Is a Phosphofructose Kinase B‐Type Enzyme With Ribose Kinase Activity
The first step in the metabolic utilization of ribose is the phosphorylation of its 5′ hydroxyl group. The enteropathogenic bacterium Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) has two known enzymes that can phosphorylate D‐ribose, namely ribose kinase (RbsK) and deoxyribose kinase (DeoK). Here, we report in vivo and in vitro evidence to support the conclusion that the previously uncharacterized STM3547 protein of this bacterium has ribose kinase activity, and we propose naming it RikA (Ribokinase A). Our bioinformatics analyses show end‐to‐end sequence identity/similarity among RikA, RbsK, and DeoK, and site‐directed mutagenesis of RikA showed that, like in RbsK and DeoK, an aspartate residue (position 343 in RikA) is critical for enzymatic activity. We found that RikA has K m values comparable to those of RbsK and DeoK for both ribose and ATP, and that all three proteins display cooperative binding of ATP induced by ribose. Together, these data suggest that the ribose‐induced conformational changes observed in E. coli RbsK also occur in all three ribose kinases of S. typhimurium . Notably, while RikA has robust ribose kinase activity, it can only poorly phosphorylate 2‐deoxy‐D‐ribose, D‐xylose, and D‐xylulose, and it cannot phosphorylate L‐arabinose. Collectively, our data support the conclusion that the RikA protein is a member of the phosphofructose kinase B‐type (PfkB) family of sugar kinases.
- Open Access
- 3 May 2026
- Published by Wiley in Molecular Microbiology
- Vol. 126 (1) , 15-23
In Salmonella Typhimurium, YiiD Modulates cAMP Levels in Lag Phase During Growth on Succinate
In Salmonella Typhimurium ( S. Typhimurium), yiiD encodes a two‐domain protein, with one domain having bona fide malonyl‐ACP decarboxylase activity, and the other showing sequence similarity to Gcn5‐type acetyltransferases (GNATs). Recent work on this enzyme was motivated by the essentiality of its decarboxylase domain to initiation of fatty acid biosynthesis in a strain devoid of β‐ketoacyl‐[acyl‐carrier‐protein, ACP] synthase III (FabH) activity. A function for the putative GNAT domain has not been established. We find that a ∆ yiiD strain has an unconventional, slow‐growth lag phenotype during growth on succinate that is only weakly dependent on YiiD decarboxylase activity, implicating the putative GNAT domain. The ∆ yiiD mutation suppresses the effect of a ∆ rpoS mutation that is known to shorten the lag phase during growth on succinate, suggesting the function of the YiiD protein may also be regulatory. Isolation of spontaneous suppressor mutations in a ∆ yiiD strain revealed changes in the promoter of cpdA , the gene encoding cyclic‐AMP phosphodiesterase. Exogenous addition of cAMP to the medium fully abrogated the ∆ yiiD phenotype, and intracellular cAMP measurements revealed that the ∆ yiiD strain fails to accumulate cAMP during lag phase, with levels about half of those measured in the wildtype strain. During the lag phase, the ∆ yiiD strain was also measured to have increased expression of the adenylate cyclase gene, cyaA , implying that the mechanism altering cAMP levels occurs posttranscriptionally. We conclude YiiD function is necessary for early cAMP accumulation during transitions into some non‐phosphotransferase system (non‐PTS) growth conditions. We suggest changing the name of the YiiD protein to LcmM (for lipid and carbon metabolism modulator) to encapsulate its roles in S. Typhimurium physiology.
- 3 May 2026
- Published by Wiley in Molecular Microbiology
- Vol. 126 (1) , 15-23
Open AccessIn Salmonella Typhimurium, YiiD Modulates cAMP Levels in Lag Phase During Growth on Succinate
In Salmonella Typhimurium ( S. Typhimurium), yiiD encodes a two‐domain protein, with one domain having bona fide malonyl‐ACP decarboxylase activity, and the other showing sequence similarity to Gcn5‐type acetyltransferases (GNATs). Recent work on this enzyme was motivated by the essentiality of its decarboxylase domain to initiation of fatty acid biosynthesis in a strain devoid of β‐ketoacyl‐[acyl‐carrier‐protein, ACP] synthase III (FabH) activity. A function for the putative GNAT domain has not been established. We find that a ∆ yiiD strain has an unconventional, slow‐growth lag phenotype during growth on succinate that is only weakly dependent on YiiD decarboxylase activity, implicating the putative GNAT domain. The ∆ yiiD mutation suppresses the effect of a ∆ rpoS mutation that is known to shorten the lag phase during growth on succinate, suggesting the function of the YiiD protein may also be regulatory. Isolation of spontaneous suppressor mutations in a ∆ yiiD strain revealed changes in the promoter of cpdA , the gene encoding cyclic‐AMP phosphodiesterase. Exogenous addition of cAMP to the medium fully abrogated the ∆ yiiD phenotype, and intracellular cAMP measurements revealed that the ∆ yiiD strain fails to accumulate cAMP during lag phase, with levels about half of those measured in the wildtype strain. During the lag phase, the ∆ yiiD strain was also measured to have increased expression of the adenylate cyclase gene, cyaA , implying that the mechanism altering cAMP levels occurs posttranscriptionally. We conclude YiiD function is necessary for early cAMP accumulation during transitions into some non‐phosphotransferase system (non‐PTS) growth conditions. We suggest changing the name of the YiiD protein to LcmM (for lipid and carbon metabolism modulator) to encapsulate its roles in S. Typhimurium physiology.
- Open Access
In Salmonella Typhimurium and Bacillus subtilis, Nucleoid-Associated HU Proteins Are N-Terminally Acetylated
Here we report that the Salmonella Typhimurium NatB (SeNatB) protein N-terminal acetyltransferase acetylated the N-terminal methionine of the nucleoid-associated HU proteins. Our findings were supported by an in vitro analysis of acetylation of the HUα and HUβ proteins and lysine-null (K-null) variants, and by an in vivo analysis of the effect of acetylation on HU-mediated transcriptional regulation of a known target of HU, the hilA promoter. SeNatB did not acetylate the initiating methionines of HU proteins that were oxidized to methionine sulfoxide, but the reduction of these methionine sulfoxide residues restored the acetylation of HU proteins by SeNatB. These results demonstrate that the SeHU proteins are bona fide substrates for the methionine sulfoxide reductases MsrA and MsrB. Finally, we showed that the Bacillus subtilis acetyltransferase, YfmK, is a functional homolog of SeNatB, and that BsYfmK acetylates the Nα amino group of the initiating methionine of the B. subtilis HU protein (HBsu).
Open AccessIn Salmonella Typhimurium and Bacillus subtilis, Nucleoid-Associated HU Proteins Are N-Terminally Acetylated
Here we report that the Salmonella Typhimurium NatB (SeNatB) protein N-terminal acetyltransferase acetylated the N-terminal methionine of the nucleoid-associated HU proteins. Our findings were supported by an in vitro analysis of acetylation of the HUα and HUβ proteins and lysine-null (K-null) variants, and by an in vivo analysis of the effect of acetylation on HU-mediated transcriptional regulation of a known target of HU, the hilA promoter. SeNatB did not acetylate the initiating methionines of HU proteins that were oxidized to methionine sulfoxide, but the reduction of these methionine sulfoxide residues restored the acetylation of HU proteins by SeNatB. These results demonstrate that the SeHU proteins are bona fide substrates for the methionine sulfoxide reductases MsrA and MsrB. Finally, we showed that the Bacillus subtilis acetyltransferase, YfmK, is a functional homolog of SeNatB, and that BsYfmK acetylates the Nα amino group of the initiating methionine of the B. subtilis HU protein (HBsu).
- 8 January 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (3) , 2380-2392
Spectroscopic and Computational Insights into the Mechanism of Cofactor Cobalt–Carbon Bond Homolysis by the Adenosylcobalamin-Dependent Enzyme Ethanolamine Ammonia-Lyase
The adenosylcobalamin (AdoCbl)-dependent enzyme ethanolamine ammonia-lyase (EAL) catalyzes the conversion of ethanolamine to acetaldehyde and ammonia. As is the case for all AdoCbl-dependent isomerases, the catalytic cycle of EAL is initiated by homolytic cleavage of the cofactor's Co-C bond, producing CoIIcobalamin (CoIICbl) and an adenosyl radical that serves to abstract a hydrogen atom from the substrate. Remarkably, in the presence of substrate, the rate of Co-C bond homolysis of enzyme-bound AdoCbl is increased by 12 orders of magnitude. For Class I AdoCbl-dependent isomerases, an important contribution to this rate acceleration stems from a stabilization of the CoIICbl posthomolysis product by the axially coordinated histidine residue that displaces the pendant base from the Co ion upon AdoCbl binding to these enzymes. However, EAL and other Class II isomerases bind AdoCbl in the so-called "base-on" conformation and must therefore employ a different mechanism of Co-C bond activation. In the present study, we have used a combined spectroscopic and computational approach to probe the conformational changes and enzyme/cofactor/substrate interactions that contribute to the rate acceleration of Co-C bond homolysis in EAL. Spectroscopic data of AdoCbl and CoIICbl show minimal perturbations upon cofactor binding to EAL in both the absence and presence of substrate. Structural models of free and EAL-bound AdoCbl were constructed using molecular dynamics and quantum mechanics/molecular mechanics computations. By carrying out relaxed potential energy scans for Co-C bond cleavage of free and EAL-bound AdoCbl, we identified key cofactor/enzyme interactions that contribute to the Co-C bond activation by EAL and obtained Co-C bond dissociation energies that agree well with published experimental data.
- 8 January 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (3) , 2380-2392
Spectroscopic and Computational Insights into the Mechanism of Cofactor Cobalt–Carbon Bond Homolysis by the Adenosylcobalamin-Dependent Enzyme Ethanolamine Ammonia-Lyase
The adenosylcobalamin (AdoCbl)-dependent enzyme ethanolamine ammonia-lyase (EAL) catalyzes the conversion of ethanolamine to acetaldehyde and ammonia. As is the case for all AdoCbl-dependent isomerases, the catalytic cycle of EAL is initiated by homolytic cleavage of the cofactor's Co-C bond, producing CoIIcobalamin (CoIICbl) and an adenosyl radical that serves to abstract a hydrogen atom from the substrate. Remarkably, in the presence of substrate, the rate of Co-C bond homolysis of enzyme-bound AdoCbl is increased by 12 orders of magnitude. For Class I AdoCbl-dependent isomerases, an important contribution to this rate acceleration stems from a stabilization of the CoIICbl posthomolysis product by the axially coordinated histidine residue that displaces the pendant base from the Co ion upon AdoCbl binding to these enzymes. However, EAL and other Class II isomerases bind AdoCbl in the so-called "base-on" conformation and must therefore employ a different mechanism of Co-C bond activation. In the present study, we have used a combined spectroscopic and computational approach to probe the conformational changes and enzyme/cofactor/substrate interactions that contribute to the rate acceleration of Co-C bond homolysis in EAL. Spectroscopic data of AdoCbl and CoIICbl show minimal perturbations upon cofactor binding to EAL in both the absence and presence of substrate. Structural models of free and EAL-bound AdoCbl were constructed using molecular dynamics and quantum mechanics/molecular mechanics computations. By carrying out relaxed potential energy scans for Co-C bond cleavage of free and EAL-bound AdoCbl, we identified key cofactor/enzyme interactions that contribute to the Co-C bond activation by EAL and obtained Co-C bond dissociation energies that agree well with published experimental data.
- Open Access
- 5 December 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (12) , e0201124
Sirtuin-dependent reversible lysine acetylation of the o -succinylbenzoyl-coenzyme A synthetase of Bacillus subtilis
Reversible lysine acylation (RLA) is a conserved posttranslational modification that cells of all domains of life use to regulate the biological function of proteins, some of which have enzymatic activity. Many AMP-forming organic acid:CoA ligases are regulated via acylation in prokaryotes and eukaryotes. Here, we report the acetylation of the o -succinylbenzoyl-CoA synthetase (EC 6.2.1.26) of Bacillus subtilis ( Bs MenE) by the GCN5-related acetyltransferase (GNAT) AcuA enzyme of this bacterium. Bs MenE is part of the metabolic pathway that assembles menaquinone (MK), an essential component of the electron transport chain in B. subtilis . We demonstrate that the active-site lysine 471 (K471) of Bs MenE is acetylated specifically by Bs AcuA, and that acetylated Bs MenE ( Bs MenE Ac ) is deacetylated by the NAD + -dependent sirtuin ( Bs SrtN) of this bacterium. The in vivo analyses performed in this study were done in an Escherichia coli Δ menE strain because the enzymatic activity of MenE is essential in B. subtilis , but not in E. coli . The use of a heterologous system allowed us to assess the effect of acetylation on Bs MenE function under MK-dependent growth conditions. Based on our in vivo data, we suggest that regulation of Bs MenE by RLA reduces MK production, negatively affecting the growth rate and yield of the culture. IMPORTANCE: Reversible lysine acylation (RLA) is a posttranslational modification used by all cells to rapidly control the biological function of proteins. Herein, we identify an acetyltransferase and deacetylase in the soil bacterium Bacillus subtilis that can modify/demodify an enzyme required for the synthesis of menaquinone (MK), an essential electron carrier involved in respiration in cells of all domains of life. Based on our data, we suggest that under some as-yet-undefined physiological conditions, B. subtilis modulates MK biosynthesis, which changes the flux of electrons through the electron transport chain of this bacterium. To our knowledge, this is the first example of control of respiration by RLA.
- 5 December 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (12) , e0201124
Open AccessSirtuin-dependent reversible lysine acetylation of the o -succinylbenzoyl-coenzyme A synthetase of Bacillus subtilis
Reversible lysine acylation (RLA) is a conserved posttranslational modification that cells of all domains of life use to regulate the biological function of proteins, some of which have enzymatic activity. Many AMP-forming organic acid:CoA ligases are regulated via acylation in prokaryotes and eukaryotes. Here, we report the acetylation of the o -succinylbenzoyl-CoA synthetase (EC 6.2.1.26) of Bacillus subtilis ( Bs MenE) by the GCN5-related acetyltransferase (GNAT) AcuA enzyme of this bacterium. Bs MenE is part of the metabolic pathway that assembles menaquinone (MK), an essential component of the electron transport chain in B. subtilis . We demonstrate that the active-site lysine 471 (K471) of Bs MenE is acetylated specifically by Bs AcuA, and that acetylated Bs MenE ( Bs MenE Ac ) is deacetylated by the NAD + -dependent sirtuin ( Bs SrtN) of this bacterium. The in vivo analyses performed in this study were done in an Escherichia coli Δ menE strain because the enzymatic activity of MenE is essential in B. subtilis , but not in E. coli . The use of a heterologous system allowed us to assess the effect of acetylation on Bs MenE function under MK-dependent growth conditions. Based on our in vivo data, we suggest that regulation of Bs MenE by RLA reduces MK production, negatively affecting the growth rate and yield of the culture. IMPORTANCE: Reversible lysine acylation (RLA) is a posttranslational modification used by all cells to rapidly control the biological function of proteins. Herein, we identify an acetyltransferase and deacetylase in the soil bacterium Bacillus subtilis that can modify/demodify an enzyme required for the synthesis of menaquinone (MK), an essential electron carrier involved in respiration in cells of all domains of life. Based on our data, we suggest that under some as-yet-undefined physiological conditions, B. subtilis modulates MK biosynthesis, which changes the flux of electrons through the electron transport chain of this bacterium. To our knowledge, this is the first example of control of respiration by RLA.
- 21 November 2024
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 206 (11) , e0028624
Corrinoid salvaging and cobamide remodeling in bacteria and archaea
Cobamides (Cbas) are cobalt-containing cyclic tetrapyrroles used by cells from all domains of life as co-catalyst of diverse reactions. There are several structural features that distinguish Cbas from one another. The most relevant of those features discussed in this review is the lower ligand, which is the nucleobase of a ribotide located in the lower face of the cyclic tetrapyrrole ring. The above-mentioned ribotide is known as the nucleotide loop, which is attached to the ring by a short linker. In Cbas, the nucleobase of the ribotide can be benzimidazole or derivatives of it, purine or derivatives of it, or phenolic compounds. Given the importance of Cbas in prokaryotic metabolism, it is not surprising that prokaryotes have evolved enzymes that cleave part or the entire nucleotide loop. This function is advantageous when Cbas contain nucleobases that somehow interfere with the function of Cba-dependent enzymes in the organism. After cleavage, Cbas are rebuilt via the nucleotide loop assembly (NLA) pathway, which includes enzymes that activate the nucleobase and the ring intermediate, followed by condensation of activated intermediates and a final dephosphorylation reaction. This exchange of nucleobases is known as Cba remodeling. The NLA pathway is used to salvage Cba precursors from the environment.
- 21 November 2024
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 206 (11) , e0028624
Corrinoid salvaging and cobamide remodeling in bacteria and archaea
Cobamides (Cbas) are cobalt-containing cyclic tetrapyrroles used by cells from all domains of life as co-catalyst of diverse reactions. There are several structural features that distinguish Cbas from one another. The most relevant of those features discussed in this review is the lower ligand, which is the nucleobase of a ribotide located in the lower face of the cyclic tetrapyrrole ring. The above-mentioned ribotide is known as the nucleotide loop, which is attached to the ring by a short linker. In Cbas, the nucleobase of the ribotide can be benzimidazole or derivatives of it, purine or derivatives of it, or phenolic compounds. Given the importance of Cbas in prokaryotic metabolism, it is not surprising that prokaryotes have evolved enzymes that cleave part or the entire nucleotide loop. This function is advantageous when Cbas contain nucleobases that somehow interfere with the function of Cba-dependent enzymes in the organism. After cleavage, Cbas are rebuilt via the nucleotide loop assembly (NLA) pathway, which includes enzymes that activate the nucleobase and the ring intermediate, followed by condensation of activated intermediates and a final dephosphorylation reaction. This exchange of nucleobases is known as Cba remodeling. The NLA pathway is used to salvage Cba precursors from the environment.
- Open Access
- 19 December 2023
- Published by American Society for Microbiology in mBio
- Vol. 14 (6) , e0273223
Campylobacter jejuni uses energy taxis and a dehydrogenase enzyme for l -fucose chemotaxis
Campylobacter jejuni is a leading cause of bacterial diarrhea worldwide, and infection in infants is associated with growth stunting in low- and middle-income countries. Approximately half of all C. jejuni isolates are asaccharolytic, while the remainder encode enzymes capable of l -fucose catabolism. Our previous study suggested that breastfed infants originating from sub-Saharan Africa and South Asia were colonized less frequently with l -fucose-metabolizing C. jejuni isolates compared to asaccharolytic strains. We also showed that FucX is an l -fucose dehydrogenase that binds to its NADP + cofactor even in the absence of l -fucose and that this enzyme is sufficient for l -fucose chemotaxis when introduced into strains lacking the metabolic pathway. This study indicates that FucX may influence l -fucose chemotaxis by increasing cellular NADPH/NADP + ratios, which subsequently affect the energy taxis components, CetABC that respond to shifting gradients of electron acceptors and donors. Furthermore, C. jejuni CetAB and CetAC can complement Escherichia coli aerotaxis. Our data support a model in which the shift in NADP + levels, impacted by the FucX dehydrogenase, affects chemotaxis in response to l -fucose. This swimming behavior can be phenocopied with a homologous l -fucose dehydrogenase from Burkholderia multivorans . Taken together, our work provides a possible explanation for why l -fucose-metabolizing C. jejuni isolates swim away from intestinal epithelial cells toward free fucose in the lumen where they are subsequently cleared by breastfed infants. IMPORTANCE: In this study, we identify a separate role for the Campylobacter jejuni l -fucose dehydrogenase in l -fucose chemotaxis and demonstrate that this mechanism is not only limited to C. jejuni but is also present in Burkholderia multivorans . We now hypothesize that l -fucose energy taxis may contribute to the reduction of l -fucose-metabolizing strains of C. jejuni from the gastrointestinal tract of breastfed infants, selecting for isolates with increased colonization potential.
- 19 December 2023
- Published by American Society for Microbiology in mBio
- Vol. 14 (6) , e0273223
Open AccessCampylobacter jejuni uses energy taxis and a dehydrogenase enzyme for l -fucose chemotaxis
Campylobacter jejuni is a leading cause of bacterial diarrhea worldwide, and infection in infants is associated with growth stunting in low- and middle-income countries. Approximately half of all C. jejuni isolates are asaccharolytic, while the remainder encode enzymes capable of l -fucose catabolism. Our previous study suggested that breastfed infants originating from sub-Saharan Africa and South Asia were colonized less frequently with l -fucose-metabolizing C. jejuni isolates compared to asaccharolytic strains. We also showed that FucX is an l -fucose dehydrogenase that binds to its NADP + cofactor even in the absence of l -fucose and that this enzyme is sufficient for l -fucose chemotaxis when introduced into strains lacking the metabolic pathway. This study indicates that FucX may influence l -fucose chemotaxis by increasing cellular NADPH/NADP + ratios, which subsequently affect the energy taxis components, CetABC that respond to shifting gradients of electron acceptors and donors. Furthermore, C. jejuni CetAB and CetAC can complement Escherichia coli aerotaxis. Our data support a model in which the shift in NADP + levels, impacted by the FucX dehydrogenase, affects chemotaxis in response to l -fucose. This swimming behavior can be phenocopied with a homologous l -fucose dehydrogenase from Burkholderia multivorans . Taken together, our work provides a possible explanation for why l -fucose-metabolizing C. jejuni isolates swim away from intestinal epithelial cells toward free fucose in the lumen where they are subsequently cleared by breastfed infants. IMPORTANCE: In this study, we identify a separate role for the Campylobacter jejuni l -fucose dehydrogenase in l -fucose chemotaxis and demonstrate that this mechanism is not only limited to C. jejuni but is also present in Burkholderia multivorans . We now hypothesize that l -fucose energy taxis may contribute to the reduction of l -fucose-metabolizing strains of C. jejuni from the gastrointestinal tract of breastfed infants, selecting for isolates with increased colonization potential.
- Open Access
- 4 September 2023
- Published by Shared Science Publishers OG in Microbial Cell
- Vol. 10 (9) , 178-194
The coenzyme B12 precursor 5,6-dimethylbenzimidazole is a flavin antagonist in Salmonella
Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) synthesizes adenosylcobalamin (AdoCbl, CoB12) de novo only under anoxic conditions, but it can assemble the lower ligand loop (a.k.a. the nucleotide loop) and can form the unique C-Co bond present in CoB(12 )in the presence or absence of molecular oxygen. During studies of nucleotide loop assembly in S. Typhimurium, we noticed that the growth of this bacterium could be arrested by the lower ligand nucleobase, namely 5,6dimethylbenzimidazole (DMB). Here we report in vitro and in vivo evidence that shows that the structural similarity of DMB to the isoalloxazine moiety of flavin cofactors causes its deleterious effect on cell growth. We studied DMB inhibition of the housekeeping flavin dehydrogenase (Fre) and three flavoenzymes that initiate the catabolism of tricarballylate, succinate or D-alanine in S. Typhimurium. Notably, while growth with tricarballylate was inhibited by 5-methyl-benzimidazole (5-Me-Bza) and DMB, growth with succinate or glycerol was arrested by DMB but not by 5-Me-Bza. Neither unsubstituted benzimidazole nor adenine inhibited growth of S. Typhimurium at DMB inhibitory concentrations. Whole genome sequencing analysis of spontaneous mutant strains that grew in the presence of inhibitory concentrations of DMB identified mutations effecting the cycA (encodes D-Ala/D-Ser transporter) and dctA (encodes dicarboxylate transporter) genes and in the coding sequence of the tricarballylate transporter (TcuC), suggesting that increased uptake of substrates relieved DMB inhibition. We discuss two possible mechanisms of inhibition by DMB.
- 4 September 2023
- Published by Shared Science Publishers OG in Microbial Cell
- Vol. 10 (9) , 178-194
Open AccessThe coenzyme B12 precursor 5,6-dimethylbenzimidazole is a flavin antagonist in Salmonella
Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) synthesizes adenosylcobalamin (AdoCbl, CoB12) de novo only under anoxic conditions, but it can assemble the lower ligand loop (a.k.a. the nucleotide loop) and can form the unique C-Co bond present in CoB(12 )in the presence or absence of molecular oxygen. During studies of nucleotide loop assembly in S. Typhimurium, we noticed that the growth of this bacterium could be arrested by the lower ligand nucleobase, namely 5,6dimethylbenzimidazole (DMB). Here we report in vitro and in vivo evidence that shows that the structural similarity of DMB to the isoalloxazine moiety of flavin cofactors causes its deleterious effect on cell growth. We studied DMB inhibition of the housekeeping flavin dehydrogenase (Fre) and three flavoenzymes that initiate the catabolism of tricarballylate, succinate or D-alanine in S. Typhimurium. Notably, while growth with tricarballylate was inhibited by 5-methyl-benzimidazole (5-Me-Bza) and DMB, growth with succinate or glycerol was arrested by DMB but not by 5-Me-Bza. Neither unsubstituted benzimidazole nor adenine inhibited growth of S. Typhimurium at DMB inhibitory concentrations. Whole genome sequencing analysis of spontaneous mutant strains that grew in the presence of inhibitory concentrations of DMB identified mutations effecting the cycA (encodes D-Ala/D-Ser transporter) and dctA (encodes dicarboxylate transporter) genes and in the coding sequence of the tricarballylate transporter (TcuC), suggesting that increased uptake of substrates relieved DMB inhibition. We discuss two possible mechanisms of inhibition by DMB.
- Open Access
- 24 August 2023
- Published by Wiley in Molecular Microbiology
- Vol. 120 (4) , 575-586
In Salmonella enterica, the pathogenicity island 2 (SPI‐2) regulator PagR regulates its own expression and the expression of a five‐gene operon that encodes transketolase C
The enteropathogen Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) utilizes a cluster of genes encoded within the pathogenicity island 2 (SPI-2) of its genome to proliferate inside macrophages. The expression of SPI-2 is controlled by a complex network of transcriptional regulators and environmental cues, which now include a recently characterized DNA-binding protein named PagR. Growth of S. Typhimurium in low-phosphate, low-magnesium medium mimics conditions inside macrophages. Under such conditions, PagR ensures SPI-2 induction by upregulating the transcription of slyA, which encodes a known activator of SPI-2. Here, we report that PagR represses the expression of a divergently transcribed polycistronic operon that encodes the two subunits of transketolase TktC (i.e., tktD, tktE) of this bacterium. Transketolases contribute to the nonredox rearrangements of phosphorylated sugars of the pentose phosphate pathway, which provide building blocks for amino acids, nucleotides, cofactors, etc. We also demonstrate that PagR represses the expression of its own gene and define two PagR-binding sites between stm2344 and pagR.
- 24 August 2023
- Published by Wiley in Molecular Microbiology
- Vol. 120 (4) , 575-586
Open AccessIn Salmonella enterica, the pathogenicity island 2 (SPI‐2) regulator PagR regulates its own expression and the expression of a five‐gene operon that encodes transketolase C
The enteropathogen Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) utilizes a cluster of genes encoded within the pathogenicity island 2 (SPI-2) of its genome to proliferate inside macrophages. The expression of SPI-2 is controlled by a complex network of transcriptional regulators and environmental cues, which now include a recently characterized DNA-binding protein named PagR. Growth of S. Typhimurium in low-phosphate, low-magnesium medium mimics conditions inside macrophages. Under such conditions, PagR ensures SPI-2 induction by upregulating the transcription of slyA, which encodes a known activator of SPI-2. Here, we report that PagR represses the expression of a divergently transcribed polycistronic operon that encodes the two subunits of transketolase TktC (i.e., tktD, tktE) of this bacterium. Transketolases contribute to the nonredox rearrangements of phosphorylated sugars of the pentose phosphate pathway, which provide building blocks for amino acids, nucleotides, cofactors, etc. We also demonstrate that PagR represses the expression of its own gene and define two PagR-binding sites between stm2344 and pagR.